This data was consistent with previous studies,55–58 which showed that β-arrestin-2, but not β-arrestin-1, mediates AngII-induced ERK1/2 activation and both thoracic aortic aneurysm and AAA formation. This evidence concerns the gene MAPK3 and triple-A syndrome.